Low-volatility stocks may offer stability, but that often comes at the cost of slower growth and the upside potential of more dynamic companies.

Luckily for you, StockStory helps you navigate which companies are truly worth holding. Keeping that in mind, here is one low-volatility stock providing safe-and-steady growth and two that may not deliver the returns you need.

Two Stocks to Sell:

Hilton (HLT)

Rolling One-Year Beta: 0.91

Founded in 1919, Hilton Worldwide (NYSE: HLT) is a global hospitality company with a portfolio of hotel brands.

Why Does HLT Worry Us?

1. Annual sales growth of 4.3% over the last five years lagged behind its consumer discretionary peers as its large revenue base made it difficult to generate incremental demand
2. Revenue per room has disappointed over the past two years due to weaker trends in its daily rates and occupancy levels
3. Estimated sales growth of 6.8% for the next 12 months implies demand will slow from its two-year trend

Hilton’s stock price of $273.42 implies a valuation ratio of 33.5x forward P/E. If you’re considering HLT for your portfolio, see our FREE research report to learn more.

Honeywell (HON)

Rolling One-Year Beta: 0.73

Originally founded in 1906 as a thermostat company, Honeywell (NASDAQ: HON) is a multinational conglomerate known for its aerospace systems, building technologies, performance materials, and safety and productivity solutions.

Why Does HON Give Us Pause?

1. Organic revenue growth fell short of our benchmarks over the past two years and implies it may need to improve its products, pricing, or go-to-market strategy
2. Earnings growth over the last five years fell short of the peer group average as its EPS only increased by 3.5% annually
3. Capital intensity has ramped up over the last five years as its free cash flow margin decreased by 3.2 percentage points

At $240.12 per share, Honeywell trades at 22.6x forward P/E. Dive into our free research report to see why there are better opportunities than HON.

One Stock to Watch:

Lantheus (LNTH)

Rolling One-Year Beta: 0.68

Pioneering the "Find, Fight and Follow" approach to disease management, Lantheus Holdings (NASDAQGM:LNTH) develops and commercializes radiopharmaceuticals and other imaging agents that help healthcare professionals detect, diagnose, and treat diseases.

Why Do We Like LNTH?

1. Annual revenue growth of 34.3% over the last five years was superb and indicates its market share increased during this cycle
2. Free cash flow margin expanded by 29.5 percentage points over the last five years, providing additional flexibility for investments and share buybacks/dividends
3. Rising returns on capital show management is finding more attractive investment opportunities

Lantheus is trading at $80.41 per share, or 11.2x forward P/E. Is now the right time to buy? Find out in our full research report, it’s free.

High-Quality Stocks for All Market Conditions

Market indices reached historic highs following Donald Trump’s presidential victory in November 2024, but the outlook for 2025 is clouded by new trade policies that could impact business confidence and growth.

While this has caused many investors to adopt a "fearful" wait-and-see approach, we’re leaning into our best ideas that can grow regardless of the political or macroeconomic climate. Take advantage of Mr. Market by checking out our Top 5 Growth Stocks for this month. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,754% five-year return). Find your next big winner with StockStory today for free. Find your next big winner with StockStory today. Find your next big winner with StockStory today